{"id":3005,"date":"2026-03-12T14:56:52","date_gmt":"2026-03-12T13:56:52","guid":{"rendered":"https:\/\/neuramancer.de\/?p=3005"},"modified":"2026-11-10T12:10:05","modified_gmt":"2026-11-10T11:10:05","slug":"neuramancer-secures-pre-seed-funding","status":"publish","type":"post","link":"https:\/\/neuramancer.de\/en\/neuramancer-secures-pre-seed-funding\/","title":{"rendered":"Neuramancer Secures Pre-Seed Funding"},"content":{"rendered":"\n<div class=\"wp-block-cover alignfull\" style=\"min-height:50px;aspect-ratio:unset;\"><img loading=\"lazy\" decoding=\"async\" width=\"1920\" height=\"1200\" class=\"wp-block-cover__image-background wp-image-400\" alt=\"\" src=\"https:\/\/neuramancer.de\/wp-content\/uploads\/2024\/08\/network-4851079_1920.jpg\" data-object-fit=\"cover\"\/><span aria-hidden=\"true\" class=\"wp-block-cover__background has-dark-gray-background-color has-background-dim-80 has-background-dim\"><\/span><div class=\"wp-block-cover__inner-container is-layout-constrained wp-block-cover-is-layout-constrained\">\n<div style=\"height:80px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<h1 class=\"wp-block-heading has-text-align-center\">Bavarian Deepfake Detection Startup Secures Pre-Seed Funding<\/h1>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\">Press Release<\/p>\n<\/div><\/div>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n<\/div><\/div>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<div class=\"wp-block-group gb-slider\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<div class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<figure class=\"wp-block-image size-full ai-generated\"><img loading=\"lazy\" decoding=\"async\" width=\"1920\" height=\"1072\" src=\"https:\/\/neuramancer.de\/wp-content\/uploads\/2026\/03\/NAIS-Notartermin-Gruppenbild_NEU.jpg\" alt=\"\" class=\"wp-image-1523\" srcset=\"https:\/\/neuramancer.de\/wp-content\/uploads\/2026\/03\/NAIS-Notartermin-Gruppenbild_NEU.jpg 1920w, https:\/\/neuramancer.de\/wp-content\/uploads\/2026\/03\/NAIS-Notartermin-Gruppenbild_NEU-300x168.jpg 300w, https:\/\/neuramancer.de\/wp-content\/uploads\/2026\/03\/NAIS-Notartermin-Gruppenbild_NEU-1024x572.jpg 1024w, https:\/\/neuramancer.de\/wp-content\/uploads\/2026\/03\/NAIS-Notartermin-Gruppenbild_NEU-768x429.jpg 768w, https:\/\/neuramancer.de\/wp-content\/uploads\/2026\/03\/NAIS-Notartermin-Gruppenbild_NEU-1536x858.jpg 1536w\" sizes=\"auto, (max-width: 1920px) 100vw, 1920px\" \/><\/figure>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1920\" height=\"1072\" src=\"https:\/\/neuramancer.de\/wp-content\/uploads\/2026\/03\/NAIS-Notartermin-Gruppenbild_HIGHLIGHT_v4b.jpg\" alt=\"\" class=\"wp-image-1517\" srcset=\"https:\/\/neuramancer.de\/wp-content\/uploads\/2026\/03\/NAIS-Notartermin-Gruppenbild_HIGHLIGHT_v4b.jpg 1920w, https:\/\/neuramancer.de\/wp-content\/uploads\/2026\/03\/NAIS-Notartermin-Gruppenbild_HIGHLIGHT_v4b-300x168.jpg 300w, https:\/\/neuramancer.de\/wp-content\/uploads\/2026\/03\/NAIS-Notartermin-Gruppenbild_HIGHLIGHT_v4b-1024x572.jpg 1024w, https:\/\/neuramancer.de\/wp-content\/uploads\/2026\/03\/NAIS-Notartermin-Gruppenbild_HIGHLIGHT_v4b-768x429.jpg 768w, https:\/\/neuramancer.de\/wp-content\/uploads\/2026\/03\/NAIS-Notartermin-Gruppenbild_HIGHLIGHT_v4b-1536x858.jpg 1536w\" sizes=\"auto, (max-width: 1920px) 100vw, 1920px\" \/><\/figure>\n<\/div><\/div>\n<\/div><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\"><strong><strong>Bavarian Deepfake Detection Startup Raises \u20ac1.7 Million in Pre-Seed Funding to Scale Its Forensic AI Technology for Detecting Synthetic Media Manipulation<\/strong><\/strong><\/p>\n\n\n\n<div style=\"height:15px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"wp-block-paragraph\">Neuramancer AI Solutions GmbH has successfully closed a \u20ac1.7 million pre-seed funding round, backed by a group of renowned investors. The round sends a strong signal for AI innovation made in Bavaria: Munich-based early-stage deep tech investor Vanagon Ventures leads the round, joined by Bayern Kapital and a consortium of other venture capital firms and business angels.<br><br><\/p>\n<\/div>\n<\/div>\n\n\n\n<div style=\"height:15px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<div class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<p class=\"wp-block-paragraph\">Deepfakes and AI-generated manipulation are no longer just a media issue \u2013 they have become a systemic risk to businesses and society. According to the German Insurance Association (GDV), insurance fraud causes billions of euros in losses every year, and generative AI is making the problem worse. Insurers are reporting significant increases in AI-generated claims evidence, ranging from fake damage photos to manipulated video calls.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">As AI models continue to improve, however, identifying fakes is becoming increasingly difficult. Building on years of research, Neuramancer has developed a highly accurate detection solution that analyzes statistical artifacts in image and video noise. This content-independent approach gives Neuramancer a structural advantage in a market where purely semantic AI detection methods are increasingly reaching their limits.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">But detection alone is not enough. Neuramancer\u2019s forensic analysis reports clearly explain how and where media has been manipulated, providing actionable insights to help combat fraud.<\/p>\n\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\">The deepfake detection market is still in its early stages, with analysts expecting it to grow into a multi-billion-euro industry in the coming years. At the same time, regulatory requirements for transparent, trustworthy and accountable AI systems are becoming increasingly stringent.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">While many providers rely on opaque black-box models, we take a science-based, fully transparent approach. We are convinced that explainable AI developed in Europe will become a strategic competitive advantage for companies looking to protect themselves against synthetic media manipulation.<br><strong>\u2013 <strong>says Co-Founder Anika Gruner<\/strong><\/strong><\/p>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"wp-block-paragraph\">As AI models continue to advance, increasingly convincing fakes are flooding the business world, driving rapid growth in the deepfake detection market. We see Neuramancer as one of Europe&#8217;s leading technological approaches to forensic AI detection.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Neuramancer stands out with its content-independent, internationally scalable technology, transparent forensic analysis and exceptionally low false positive rate \u2013 all essential factors for large-scale, real-world applications.<br><strong>\u2013 Susanne Fromm, Co-Founder &amp; General Partner, Vanagon VC<\/strong><\/p>\n<\/blockquote>\n\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\"><strong><strong>Market Entry and New Use Cases: Neuramancer Enters the Scaling Phase with a New Addition to the Team<\/strong><\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">With the new year, Neuramancer is stepping up its focus on commercialisation, welcoming an experienced new addition to the team. Martin Sondenheimer (formerly of Munich Re and Allianz) joins as Chief Commercial Officer, strengthening the leadership team and driving Neuramancer\u2019s market expansion and growth.<\/p>\n\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\">The insurance industry is a key market for us, as insurance fraud involving AI-generated and manipulated images and documents is becoming increasingly difficult to detect. Neuramancer\u2019s technology not only enables highly reliable detection of a wide range of manipulations but also provides the forensic analysis needed to support targeted fraud prevention while minimising false positives.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Beyond insurance, we see significant potential in many other application areas, which we plan to explore over the course of this year. The latest funding round comes amid rapidly growing demand from the insurance and digital platform sectors.<br><strong>-says Chief Commercial Officer Martin Sondenheimer<\/strong><\/p>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"wp-block-paragraph\">Deepfakes and other AI-manipulated content are increasingly becoming a real business risk for companies. Neuramancer has developed its own technology platform, independent of large AI models, to help businesses detect precisely this type of content. As AI technology continues to advance rapidly, this is becoming an increasingly important capability for companies. Neuramancer is therefore exceptionally well positioned in a fast-growing market.<br><strong>\u2013 adds Monika Steger, Managing Director of Bayern Kapital<\/strong><\/p>\n\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n<\/blockquote>\n\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\"><strong><strong>An Experienced Investor Consortium<\/strong><\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Alongside the lead investors, the consortium includes newly established Nuremberg-based ZOHO.VC and family office Lightfield Equity. The founding team will also benefit from the support of business angels with extensive experience in financial services and Big Tech, as well as successful founders of renowned platforms.<\/p>\n\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\">To reliably detect synthetic media in the long term, you need to understand how digital content is created at a technical level. This is the foundation of our proprietary algorithms. While many providers rely on generic AI models, we use forensic methods, probabilistic modelling and fully transparent decision-making processes. This makes our technology resilient to the next generation of AI systems.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In a rapidly growing market, we are now strategically expanding our team to further strengthen our technological expertise and position Neuramancer as a European leader in forensic AI innovation.<br><strong><strong>\u2013 says Anatol Maier, Co-Founder of Neuramancer<\/strong><\/strong><\/p>\n<\/blockquote>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\"><strong>About Neuramancer AI Solutions GmbH<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Neuramancer AI Solutions GmbH has developed proprietary deepfake detection technology that analyses statistical artifacts in image and video noise, regardless of the visual content. This approach is combined with probabilistic AI techniques to make the analysis results highly explainable. For example, manipulations can be visualised using heatmaps that show exactly where AI-generated alterations have occurred.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Co-Founder Anatol Maier originally developed the methodology as part of his research at Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg (Chair of IT Security). Together with the Neuramancer tech team, he further refined the algorithms during a SPRIND Challenge, an innovation competition organised by the Federal Agency for Breakthrough Innovation. The resulting technology enables particularly robust detection of AI-generated content and image manipulations.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The company focuses on close collaboration with research institutions, building a strong network within the German AI community and establishing a trusted brand that protects European businesses against disinformation and fraud. Neuramancer&#8217;s experts have already been consulted multiple times by fact-checking teams to assess questionable videos and images.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The company was founded in 2024 by Anika Gruner and Anatol Maier as part of the Media Lab Bayern Start-up Fellowship.<\/p>\n<\/div><\/div>\n\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns are-vertically-aligned-center is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"600\" height=\"350\" src=\"https:\/\/neuramancer.de\/wp-content\/uploads\/2026\/03\/vanagon-logo.jpg\" alt=\"\" class=\"wp-image-1502\" srcset=\"https:\/\/neuramancer.de\/wp-content\/uploads\/2026\/03\/vanagon-logo.jpg 600w, https:\/\/neuramancer.de\/wp-content\/uploads\/2026\/03\/vanagon-logo-300x175.jpg 300w\" sizes=\"auto, (max-width: 600px) 100vw, 600px\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<p class=\"has-medium-font-size wp-block-paragraph\"><strong>About Vanagon Ventures<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Vanagon Ventures is a Munich-based (pre-)seed deep tech venture capital fund. It invests in AI-native companies at the intersection of digital deep tech and industrial transformation.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The fund focuses on founders with deep industry expertise and a long-term vision who are building scalable business models that combine strong economic performance with measurable environmental and societal impact.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.vanagon.vc\/\">https:\/\/www.vanagon.vc\/<\/a><\/p>\n<\/div>\n<\/div>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns are-vertically-aligned-center is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"600\" height=\"350\" src=\"https:\/\/neuramancer.de\/wp-content\/uploads\/2026\/03\/bayern-kapital-logo.jpg\" alt=\"\" class=\"wp-image-1504\" srcset=\"https:\/\/neuramancer.de\/wp-content\/uploads\/2026\/03\/bayern-kapital-logo.jpg 600w, https:\/\/neuramancer.de\/wp-content\/uploads\/2026\/03\/bayern-kapital-logo-300x175.jpg 300w\" sizes=\"auto, (max-width: 600px) 100vw, 600px\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<p class=\"has-medium-font-size wp-block-paragraph\"><strong>About Bayern Kapital<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Bayern Kapital is one of the most experienced and well-capitalised venture capital investors in the DACH region. With approximately \u20ac1.3 billion in assets under management, more than 120 active portfolio companies and investments of up to \u20ac50 million per company, Bayern Kapital is one of the few investors in the market able to provide funding across all stages \u2013 from pre-seed to global growth and scale-up rounds \u2013 through a single investment partner.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">As a public venture capital investor, Bayern Kapital invests alongside leading national and international VC funds, supporting tech startups and scale-ups as a reliable anchor investor across multiple funding rounds.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Since 1995, Bayern Kapital has invested more than \u20ac675 million of its own capital in around 390 startups and scale-ups across sectors including deep tech, life sciences, AI, climate tech, SaaS, New Space and quantum technology. Its many success stories from Bavaria include EGYM, plancq, SimScale, Tubulis, Quantum Systems and OroraTech.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"http:\/\/www.bayernkapital.de\" type=\"link\" id=\"www.bayernkapital.de\">www.bayernkapital.de<\/a><\/p>\n<\/div>\n<\/div>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<p class=\"wp-block-paragraph\"><em><strong>Neuramancer AI Solutions GmbH<\/strong> \u2013Rosenheim\/ M\u00fcnchen \u2013 March 12, 2026<\/em><\/p>\n<\/div><\/div>\n\n\n\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bavarian Deepfake Detection Startup Raises \u20ac1.7 Million in Pre-Seed Funding to Scale Its Forensic AI Technology for Detecting Synthetic Media Manipulation Neuramancer AI Solutions GmbH has successfully closed a \u20ac1.7 million pre-seed funding round, backed by a group of renowned investors. The round sends a strong signal for AI innovation made in Bavaria: Munich-based early-stage [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":1524,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-3005","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-allgemein"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Neuramancer Secures Pre-Seed Funding - Neuramancer<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/neuramancer.de\/en\/neuramancer-secures-pre-seed-funding\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neuramancer Secures Pre-Seed Funding - Neuramancer\" \/>\n<meta property=\"og:description\" content=\"Bavarian Deepfake Detection Startup Raises \u20ac1.7 Million in Pre-Seed Funding to Scale Its Forensic AI Technology for Detecting Synthetic Media Manipulation Neuramancer AI Solutions GmbH has successfully closed a \u20ac1.7 million pre-seed funding round, backed by a group of renowned investors. The round sends a strong signal for AI innovation made in Bavaria: Munich-based early-stage [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/neuramancer.de\/en\/neuramancer-secures-pre-seed-funding\/\" \/>\n<meta property=\"og:site_name\" content=\"Neuramancer\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-12T13:56:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-10T11:10:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/neuramancer.de\/wp-content\/uploads\/2026\/03\/NAIS-Notartermin-Gruppenbild_NEU.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1072\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Carlotta Tilsner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Carlotta Tilsner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/neuramancer.de\\\/en\\\/neuramancer-secures-pre-seed-funding\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neuramancer.de\\\/en\\\/neuramancer-secures-pre-seed-funding\\\/\"},\"author\":{\"name\":\"Carlotta Tilsner\",\"@id\":\"https:\\\/\\\/neuramancer.de\\\/en\\\/#\\\/schema\\\/person\\\/4f64dbac36101c76aa31ca80c663efc4\"},\"headline\":\"Neuramancer Secures Pre-Seed Funding\",\"datePublished\":\"2026-03-12T13:56:52+00:00\",\"dateModified\":\"2026-11-10T11:10:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/neuramancer.de\\\/en\\\/neuramancer-secures-pre-seed-funding\\\/\"},\"wordCount\":1183,\"publisher\":{\"@id\":\"https:\\\/\\\/neuramancer.de\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/neuramancer.de\\\/en\\\/neuramancer-secures-pre-seed-funding\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neuramancer.de\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/NAIS-Notartermin-Gruppenbild_NEU.jpg\",\"articleSection\":[\"Allgemein\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/neuramancer.de\\\/en\\\/neuramancer-secures-pre-seed-funding\\\/\",\"url\":\"https:\\\/\\\/neuramancer.de\\\/en\\\/neuramancer-secures-pre-seed-funding\\\/\",\"name\":\"Neuramancer Secures Pre-Seed Funding - Neuramancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neuramancer.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/neuramancer.de\\\/en\\\/neuramancer-secures-pre-seed-funding\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/neuramancer.de\\\/en\\\/neuramancer-secures-pre-seed-funding\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neuramancer.de\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/NAIS-Notartermin-Gruppenbild_NEU.jpg\",\"datePublished\":\"2026-03-12T13:56:52+00:00\",\"dateModified\":\"2026-11-10T11:10:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/neuramancer.de\\\/en\\\/neuramancer-secures-pre-seed-funding\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/neuramancer.de\\\/en\\\/neuramancer-secures-pre-seed-funding\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/neuramancer.de\\\/en\\\/neuramancer-secures-pre-seed-funding\\\/#primaryimage\",\"url\":\"https:\\\/\\\/neuramancer.de\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/NAIS-Notartermin-Gruppenbild_NEU.jpg\",\"contentUrl\":\"https:\\\/\\\/neuramancer.de\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/NAIS-Notartermin-Gruppenbild_NEU.jpg\",\"width\":1920,\"height\":1072},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/neuramancer.de\\\/en\\\/neuramancer-secures-pre-seed-funding\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/neuramancer.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neuramancer Secures Pre-Seed Funding\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/neuramancer.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/neuramancer.de\\\/en\\\/\",\"name\":\"Neuramancer\",\"description\":\"Unmasking Deception  Ensuring Media Integrity\",\"publisher\":{\"@id\":\"https:\\\/\\\/neuramancer.de\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/neuramancer.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/neuramancer.de\\\/en\\\/#organization\",\"name\":\"Neuramancer AI Solutions GmbH\",\"url\":\"https:\\\/\\\/neuramancer.de\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/neuramancer.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/neuramancer.de\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/nm_logo-gradient-on-blue.png\",\"contentUrl\":\"https:\\\/\\\/neuramancer.de\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/nm_logo-gradient-on-blue.png\",\"width\":1890,\"height\":995,\"caption\":\"Neuramancer AI Solutions GmbH\"},\"image\":{\"@id\":\"https:\\\/\\\/neuramancer.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/neuramancer\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/neuramancer.de\\\/en\\\/#\\\/schema\\\/person\\\/4f64dbac36101c76aa31ca80c663efc4\",\"name\":\"Carlotta Tilsner\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/493431939479c328b49609f873e747d7fff6855ba2a7fb99dcdbcfbe14609d76?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/493431939479c328b49609f873e747d7fff6855ba2a7fb99dcdbcfbe14609d76?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/493431939479c328b49609f873e747d7fff6855ba2a7fb99dcdbcfbe14609d76?s=96&d=mm&r=g\",\"caption\":\"Carlotta Tilsner\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Neuramancer Secures Pre-Seed Funding - Neuramancer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/neuramancer.de\/en\/neuramancer-secures-pre-seed-funding\/","og_locale":"en_US","og_type":"article","og_title":"Neuramancer Secures Pre-Seed Funding - Neuramancer","og_description":"Bavarian Deepfake Detection Startup Raises \u20ac1.7 Million in Pre-Seed Funding to Scale Its Forensic AI Technology for Detecting Synthetic Media Manipulation Neuramancer AI Solutions GmbH has successfully closed a \u20ac1.7 million pre-seed funding round, backed by a group of renowned investors. The round sends a strong signal for AI innovation made in Bavaria: Munich-based early-stage [&hellip;]","og_url":"https:\/\/neuramancer.de\/en\/neuramancer-secures-pre-seed-funding\/","og_site_name":"Neuramancer","article_published_time":"2026-03-12T13:56:52+00:00","article_modified_time":"2026-11-10T11:10:05+00:00","og_image":[{"width":1920,"height":1072,"url":"https:\/\/neuramancer.de\/wp-content\/uploads\/2026\/03\/NAIS-Notartermin-Gruppenbild_NEU.jpg","type":"image\/jpeg"}],"author":"Carlotta Tilsner","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Carlotta Tilsner","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/neuramancer.de\/en\/neuramancer-secures-pre-seed-funding\/#article","isPartOf":{"@id":"https:\/\/neuramancer.de\/en\/neuramancer-secures-pre-seed-funding\/"},"author":{"name":"Carlotta Tilsner","@id":"https:\/\/neuramancer.de\/en\/#\/schema\/person\/4f64dbac36101c76aa31ca80c663efc4"},"headline":"Neuramancer Secures Pre-Seed Funding","datePublished":"2026-03-12T13:56:52+00:00","dateModified":"2026-11-10T11:10:05+00:00","mainEntityOfPage":{"@id":"https:\/\/neuramancer.de\/en\/neuramancer-secures-pre-seed-funding\/"},"wordCount":1183,"publisher":{"@id":"https:\/\/neuramancer.de\/en\/#organization"},"image":{"@id":"https:\/\/neuramancer.de\/en\/neuramancer-secures-pre-seed-funding\/#primaryimage"},"thumbnailUrl":"https:\/\/neuramancer.de\/wp-content\/uploads\/2026\/03\/NAIS-Notartermin-Gruppenbild_NEU.jpg","articleSection":["Allgemein"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/neuramancer.de\/en\/neuramancer-secures-pre-seed-funding\/","url":"https:\/\/neuramancer.de\/en\/neuramancer-secures-pre-seed-funding\/","name":"Neuramancer Secures Pre-Seed Funding - Neuramancer","isPartOf":{"@id":"https:\/\/neuramancer.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/neuramancer.de\/en\/neuramancer-secures-pre-seed-funding\/#primaryimage"},"image":{"@id":"https:\/\/neuramancer.de\/en\/neuramancer-secures-pre-seed-funding\/#primaryimage"},"thumbnailUrl":"https:\/\/neuramancer.de\/wp-content\/uploads\/2026\/03\/NAIS-Notartermin-Gruppenbild_NEU.jpg","datePublished":"2026-03-12T13:56:52+00:00","dateModified":"2026-11-10T11:10:05+00:00","breadcrumb":{"@id":"https:\/\/neuramancer.de\/en\/neuramancer-secures-pre-seed-funding\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/neuramancer.de\/en\/neuramancer-secures-pre-seed-funding\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/neuramancer.de\/en\/neuramancer-secures-pre-seed-funding\/#primaryimage","url":"https:\/\/neuramancer.de\/wp-content\/uploads\/2026\/03\/NAIS-Notartermin-Gruppenbild_NEU.jpg","contentUrl":"https:\/\/neuramancer.de\/wp-content\/uploads\/2026\/03\/NAIS-Notartermin-Gruppenbild_NEU.jpg","width":1920,"height":1072},{"@type":"BreadcrumbList","@id":"https:\/\/neuramancer.de\/en\/neuramancer-secures-pre-seed-funding\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/neuramancer.de\/en\/"},{"@type":"ListItem","position":2,"name":"Neuramancer Secures Pre-Seed Funding"}]},{"@type":"WebSite","@id":"https:\/\/neuramancer.de\/en\/#website","url":"https:\/\/neuramancer.de\/en\/","name":"Neuramancer","description":"Unmasking Deception  Ensuring Media Integrity","publisher":{"@id":"https:\/\/neuramancer.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/neuramancer.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/neuramancer.de\/en\/#organization","name":"Neuramancer AI Solutions GmbH","url":"https:\/\/neuramancer.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/neuramancer.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/neuramancer.de\/wp-content\/uploads\/2025\/09\/nm_logo-gradient-on-blue.png","contentUrl":"https:\/\/neuramancer.de\/wp-content\/uploads\/2025\/09\/nm_logo-gradient-on-blue.png","width":1890,"height":995,"caption":"Neuramancer AI Solutions GmbH"},"image":{"@id":"https:\/\/neuramancer.de\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/neuramancer"]},{"@type":"Person","@id":"https:\/\/neuramancer.de\/en\/#\/schema\/person\/4f64dbac36101c76aa31ca80c663efc4","name":"Carlotta Tilsner","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/493431939479c328b49609f873e747d7fff6855ba2a7fb99dcdbcfbe14609d76?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/493431939479c328b49609f873e747d7fff6855ba2a7fb99dcdbcfbe14609d76?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/493431939479c328b49609f873e747d7fff6855ba2a7fb99dcdbcfbe14609d76?s=96&d=mm&r=g","caption":"Carlotta Tilsner"}}]}},"_links":{"self":[{"href":"https:\/\/neuramancer.de\/en\/wp-json\/wp\/v2\/posts\/3005","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neuramancer.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neuramancer.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neuramancer.de\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/neuramancer.de\/en\/wp-json\/wp\/v2\/comments?post=3005"}],"version-history":[{"count":2,"href":"https:\/\/neuramancer.de\/en\/wp-json\/wp\/v2\/posts\/3005\/revisions"}],"predecessor-version":[{"id":3007,"href":"https:\/\/neuramancer.de\/en\/wp-json\/wp\/v2\/posts\/3005\/revisions\/3007"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neuramancer.de\/en\/wp-json\/wp\/v2\/media\/1524"}],"wp:attachment":[{"href":"https:\/\/neuramancer.de\/en\/wp-json\/wp\/v2\/media?parent=3005"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neuramancer.de\/en\/wp-json\/wp\/v2\/categories?post=3005"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neuramancer.de\/en\/wp-json\/wp\/v2\/tags?post=3005"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}